title: Inflammation in acute CNS injury: a focus on the role of substance P.
abstract: Recently, a number of reports have shown that neurogenic inflammation may play a role in the secondary injury response following acute injury to the CNS, including traumatic brain injury (TBI) and stroke. In particular substance P (SP) release appears to be critically involved. Specifically, the expression of the neuropeptide SP is increased in acute CNS injury, with the magnitude of SP release being related to both the frequency and magnitude of the insult. SP release is associated with an increase in blood-brain barrier permeability and the development of vasogenic oedema as well as neuronal injury and worse functional outcome. Moreover, inhibiting the actions of SP through use of a NK1 receptor antagonist is highly beneficial in both focal and diffuse models of TBI, as well as in ischaemic stroke, with a therapeutic window of up to 12 h. We propose that NK1 receptor antagonists represent a novel therapeutic option for treatment of neurogenic inflammation following acute CNS injury.
authors.affiliation: Adelaide Centre for Neuroscience Research, The University of Adelaide, Adelaide, SA, Australia.
authors.forename: F
authors.initials: F
authors.lastname: Corrigan
authors.affiliation: Division of Health Sciences, University of South Australia, Adelaide, SA, Australia.
authors.forename: R
authors.initials: R
authors.lastname: Vink
authors.affiliation: Adelaide Centre for Neuroscience Research, The University of Adelaide, Adelaide, SA, Australia.
authors.forename: R J
authors.initials: RJ
authors.lastname: Turner
mesh_terms: D000818:Animals; D002490:Central Nervous System / Q000187:drug effects / Q000293:injuries* / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism*; D064729:Neurokinin-1 Receptor Antagonists / Q000494:pharmacology; D013373:Substance P / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D064729:Neurokinin-1 Receptor Antagonists; D013373:Substance P
references.citation: Neuroscience. 1986 Apr;17(4):1011-45
references.pmid: 2423919
references.citation: Amino Acids. 2006 Oct;31(3):251-72
references.pmid: 16820980
references.citation: Neuroscience. 2012 Jul 12;214:78-83
references.pmid: 22531375
references.citation: Pharmacol Rev. 2002 Jun;54(2):285-322
references.pmid: 12037144
references.citation: J Head Trauma Rehabil. 2003 Jul-Aug;18(4):307-16
references.pmid: 16222127
references.citation: Curr Opin Crit Care. 2002 Apr;8(2):101-5
references.pmid: 12386508
references.citation: Neurosurgery. 2005 Feb;56(2):364-74; discussion 364-74
references.pmid: 15670384
references.citation: J Neuroimmunol. 2002 Oct;131(1-2):41-9
references.pmid: 12458035
references.citation: J Neurosurg. 1995 Dec;83(6):1051-9
references.pmid: 7490620
references.citation: Gen Pharmacol. 1998 Jan;30(1):5-11
references.pmid: 9457475
references.citation: Ann N Y Acad Sci. 1994 Jun 17;723:246-57
references.pmid: 7518201
references.citation: Am J Physiol. 1992 Nov;263(5 Pt 1):G678-82
references.pmid: 1279983
references.citation: J Neurotrauma. 2006 Oct;23(10):1518-28
references.pmid: 17020486
references.citation: Nat Neurosci. 2001 Apr;4(4):382-90
references.pmid: 11276228
references.citation: Neuroscience. 2012 Sep 18;220:1-10
references.pmid: 22750240
references.citation: Br J Pharmacol. 2013 Dec;170(8):1582-606
references.pmid: 24528238
references.citation: J Cereb Blood Flow Metab. 2009 Aug;29(8):1388-98
references.pmid: 19436311
references.citation: Pharmacol Rev. 1994 Dec;46(4):551-99
references.pmid: 7534932
references.citation: Neuroimmunomodulation. 1996 Jan-Feb;3(1):35-46
references.pmid: 8892359
references.citation: J Am Coll Nutr. 2004 Oct;23(5):538S-540S
references.pmid: 15466960
references.citation: J Immunol. 2008 Nov 1;181(9):6406-16
references.pmid: 18941231
references.citation: Nature. 1997 Apr 17;386(6626):721-4
references.pmid: 9109489
references.citation: Trends Neurosci. 2001 Dec;24(12):719-25
references.pmid: 11718877
references.citation: Neurotherapeutics. 2010 Jan;7(1):74-80
references.pmid: 20129499
references.citation: J Intern Med. 2001 Jan;249(1):27-40
references.pmid: 11168782
references.citation: Brain Sci. 2013 Jan 30;3(1):123-42
references.pmid: 24961310
references.citation: J Allergy Clin Immunol. 1993 Oct;92(4):589-98
references.pmid: 7691915
references.citation: Adv Exp Med Biol. 2001;493:247-54
references.pmid: 11727773
references.citation: J Rheumatol. 1989 Aug;16(8):1033-7
references.pmid: 2479743
references.citation: CNS Neurosci Ther. 2012 Jun;18(6):513-5
references.pmid: 22672307
references.citation: J Immunol. 2008 Jun 15;180(12):8241-9
references.pmid: 18523290
references.citation: Lancet Neurol. 2008 Aug;7(8):728-41
references.pmid: 18635021
references.citation: J Clin Psychiatry. 2002;63 Suppl 11:6-10
references.pmid: 12562137
references.citation: Science. 1989 May 19;244(4906):798-800
references.pmid: 2567056
references.citation: Neurochem Int. 2007 Jun;50(7-8):941-53
references.pmid: 17576023
references.citation: Br J Pharmacol. 2013 Dec;170(8):1459-581
references.pmid: 24517644
references.citation: J Immunol. 1999 Nov 15;163(10):5656-65
references.pmid: 10553096
references.citation: Nucleic Acids Res. 2014 Jan;42(Database issue):D1098-106
references.pmid: 24234439
references.citation: Arch Neurol. 1996 Apr;53(4):309-15
references.pmid: 8929152
references.citation: Mol Pharmacol. 2007 Dec;72(6):1411-8
references.pmid: 17890358
references.citation: Resuscitation. 2001 Jan;48(1):77-90
references.pmid: 11162885
references.citation: Neuroscience. 2011 Mar 17;177:308-20
references.pmid: 21215796
references.citation: Br J Pharmacol. 2013 Dec;170(8):1797-867
references.pmid: 24528243
references.citation: J Neurotrauma. 2011 Feb;28(2):217-24
references.pmid: 21175297
references.citation: J Cereb Blood Flow Metab. 2013 Jul;33(7):1075-82
references.pmid: 23571283
references.citation: J Cereb Blood Flow Metab. 2004 Feb;24(2):133-50
references.pmid: 14747740
references.citation: Vascul Pharmacol. 2002 Nov;39(4-5):171-2
references.pmid: 12747957
references.citation: Neurosci Lett. 2010 Aug 30;481(1):26-9
references.pmid: 20600611
references.citation: Cytokine Growth Factor Rev. 1999 Jun;10(2):119-30
references.pmid: 10743503
references.citation: J Clin Neurosci. 2012 Aug;19(8):1159-64
references.pmid: 22705132
references.citation: Acta Neurochir (Wien). 2006 Mar;148(3):255-68; discussion 268
references.pmid: 16311842
references.citation: J Cell Physiol. 2004 Nov;201(2):167-80
references.pmid: 15334652
references.citation: Br J Pharmacol. 2016 Feb;173(4):703-15
references.pmid: 25827155
references.citation: Crit Rev Oral Biol Med. 2004 Jan 1;15(2):82-98
references.pmid: 15059944
references.citation: Neuropeptides. 2004 Feb;38(1):40-7
references.pmid: 15003715
references.citation: Neurochem Int. 2006 Apr;48(5):394-403
references.pmid: 16473439
references.citation: Neuropeptides. 2000 Oct;34(5):256-71
references.pmid: 11049730
references.citation: Brain Res Brain Res Rev. 2002 Jun;39(1):55-73
references.pmid: 12086708
references.citation: Br J Pharmacol. 2013 Dec;170(8):1706-96
references.pmid: 24528242
references.citation: J Neurosci. 1997 Aug 1;17(15):5921-7
references.pmid: 9221788
references.citation: Eur J Neurosci. 2004 Jan;19(1):65-75
references.pmid: 14750964
references.citation: J Neurosurg. 1998 Oct;89(4):507-18
references.pmid: 9761042
references.citation: J Neurotrauma. 2004 Nov;21(11):1562-72
references.pmid: 15684649
references.citation: Int J Stroke. 2012 Jul;7(5):419-25
references.pmid: 22463085
references.citation: Stroke. 1997 Oct;28(10):2067-77
references.pmid: 9341720
references.citation: J Neurosurg. 1994 Feb;80(2):291-300
references.pmid: 8283269
references.citation: Acta Neurochir Suppl. 2006;96:263-6
references.pmid: 16671467
references.citation: Recent Pat CNS Drug Discov. 2009 Jun;4(2):86-95
references.pmid: 19519558
references.citation: Arch Surg. 1998 Oct;133(10):1107-16
references.pmid: 9790210
references.citation: J Neuropathol Exp Neurol. 2003 Feb;62(2):127-36
references.pmid: 12578222
references.citation: Neuroscience. 1991;40(1):67-80
references.pmid: 1711177
references.citation: PLoS One. 2012;7(7):e42157
references.pmid: 22848737
references.citation: J Comp Neurol. 1988 Nov 8;277(2):302-12
references.pmid: 2466061
references.citation: Neuropeptides. 2014 Oct;48(5):267-72
references.pmid: 25151181
references.citation: Neurosci Lett. 1990 Jan 1;108(1-2):155-60
references.pmid: 1689473
references.citation: Neurosci Lett. 1993 Jan 4;149(1):75-8
references.pmid: 8469386
references.citation: Gen Pharmacol. 1995 Sep;26(5):911-44
references.pmid: 7557266
references.citation: Leg Med (Tokyo). 2009 Apr;11 Suppl 1:S128-31
references.pmid: 19303345
references.citation: Acta Neurochir Suppl. 2013;118:201-4
references.pmid: 23564132
references.citation: J Trauma Acute Care Surg. 2012 Oct;73(4 Suppl 3):S248-53
references.pmid: 23026962
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):341-2
references.pmid: 6633673
references.citation: Neuropharmacology. 2001 Mar;40(3):416-23
references.pmid: 11166334
references.citation: Neurotherapeutics. 2010 Jan;7(1):22-30
references.pmid: 20129494
references.citation: Acta Neuropathol. 1999 Mar;97(3):297-305
references.pmid: 10090678
references.citation: Brain Res. 2004 Jun 4;1010(1-2):117-26
references.pmid: 15126124
references.citation: Mol Neurobiol. 2010 Jun;41(2-3):242-7
references.pmid: 20195798
references.citation: Int J Biochem Cell Biol. 2001 Jun;33(6):555-76
references.pmid: 11378438
references.citation: Biochem J. 1994 Oct 1;303 ( Pt 1):177-86
references.pmid: 7524481
references.citation: J Neurotrauma. 2005 Jan;22(1):42-75
references.pmid: 15665602
references.citation: Am J Physiol. 1992 Sep;263(3 Pt 2):R734-7
references.pmid: 1384353
references.citation: Acta Neurochir Suppl. 2010;106:211-6
references.pmid: 19812951
references.citation: Neuroreport. 1995 Dec 29;7(1):310-2
references.pmid: 8742477
references.citation: J Clin Neurosci. 1999 Nov;6(6):505-9
references.pmid: 18639191
references.citation: Brain Res. 2011 Jun 1;1393:84-90
references.pmid: 21466790
references.citation: J Neuropathol Exp Neurol. 1996 Jul;55(7):850-60
references.pmid: 8965100
references.citation: Eur J Neurosci. 2002 Nov;16(10):1896-906
references.pmid: 12453053